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CASE REPORT 
Back pain as first presentation of  
Hepatocellular Carcinoma                                         
Anil Kumar, Ikhwan Sani Mohamad, Maya Mazuwin Yahya, Leow Voon Meng, Zaidi Zakaria 
Hepatocellular Carcinoma (HCC) is known to be one of the leading 
causes of deaths globally. In Malaysia HCC is known to be the eight 
most common cancer in both genders and the fifth most common 
cancer for males. 
The etiological factors associated with HCC are chronic Hepatitis B or 
C viral infection, liver cirrhosis and nonalcoholic fatty liver disease. 
Patients with HCC usually present with right upper quadrant pain, 
jaundice, loss of weight, and a palpable mass over the right 
hypochondrium. 
This case report will describe and discuss about the diagnosis of HCC 
in a patient with an atypical presentation of back pain which was 
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INTRODUCTION 
Hepatocellular Carcinoma (HCC) is known to 
be one of the leading causes of deaths 
globally. In Malaysia HCC is known to be the 
eight most common cancer in both genders 
and the fifth most common cancer for males.1 
The etiological factors associated with HCC are 
chronic Hepatitis B or C viral infection, liver 
cirrhosis and nonalcoholic fatty liver disease. 
Patients with HCC usually present with right 
upper quadrant pain, jaundice, loss of weight, 
ascites and a palpable mass over the right 
hypochondrium.2 Hepatocellular carcinoma is 
commonly diagnosed after the symptoms have 
presented or usually in intermediate or end 
stage of HCC. If early diagnosis was done and 
treatment was received, the survival rate could 
increase up to 50%.3  
CASE REPORT 
A 58-year-old gentleman presented to our 
hospital with complaint of severe back pain for 
the past 5 months. The pain was described as 
dull persistent in nature which was relieved by 
analgesics and leaning forward. On further 
questioning the patient also claimed to have 
significant loss of weight over the past 1 
month. The patient had no history of alcohol 
consumption and family history of malignancy. 
Abdominal examination revealed 
hepatomegaly with an ill-defined liver border. 
There was no clinical evidence of ascites or 
other stigmata of chronic liver disease.  
The biochemical parameters revealed normal 
liver function test. Serological findings 
including of hepatitis B was positive. The alpha 
fetoprotein was markedly elevated with value 
of 24 980 ng/ml (N:<8.5 ng/ml) . 
The patient was subjected for a CECT Liver 4 
phase. The findings included: large ill-defined 
peripherally enhancing mass occupying 
segment 5 and 6 measuring 6x13x7cm (Figure 
1). Central hypodensity seen within the mass 
suggestive of necrotic areas. This mass 
medially involves the head of the pancreas and 
laterally displays a poor fat plane with the 
adjacent D2 segment of the duodenum. Filling 
defect seen within the right posterior portal 
vein was suggestive of thrombosis. Multiple 
enlarged matted lymph nodes in the porta 
hepatis, paracaval, aortacaval and paraaortic 
areas at the level of the renal veins. 
Hyperdense lesion was also present at body of 
Lumbar (L2) Vertebrae (Figure 2). 
The case was diagnosed as multicentric 
advanced hepatocellular carcinoma with 
nodal, bone (L2) and pancreatic involvement. 
An ultrasound guided liver biopsy was 
subsequently done and the results were 
suggestive of a moderately differentiated 
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DISCUSSION 
In normal circumstances, the prostate, breast, 
kidney, lung, and thyroid are the most 
frequently encountered cancers that 
metastasize to the bone.4 The bone metastasis 
from HCC is considered rare unless it is due to 
local infiltration by adjacent liver mass. In this 
particular case, the CT Liver 4 Phase, MRI liver 
and the elevated AFP level were highly 
suggestive of HCC.  
Bone metastasis as the first sign of 
extrahepatic HCC very seldom occurs. Due to 
this there has only been a few case reports that 
has been reported. In one study which included 
149 patients with extrahepatic metastasis of 
HCC, the most frequently involved sites of 
extrahepatic metastasis were lung, lymph 
node, musculoskeletal, and adrenal gland in 
order of frequency.4Most of the 
musculoskeletal involvements (66%) already 
had multiple other no osseous sites of 
metastatic disease at the time of presentation 
of the first documented extrahepatic HCC. 
However, isolated bone metastasis as the first 
manifestation was only seen in 14 out of 149 
(9.5%) patients. The most frequently involved 
location was the lumbosacral and thoracic 
spine.3,5 
The pathogenic mechanism of spinal 
metastasis are as follows: (1) The coexistence 
of pulmonary and brain metastases supports 
the conclusion of dissemination through the 
arterial route; (2) the other is spread through 
the vertebral venous plexus, extending from 
the pelvis to the cranial venous sinuses, 
enabling retrograde transportation to the 
spinal cord; (3) direct invasion from contiguous 
structures; and (4) intraspinal 
dissemination.3Since symptoms attributable 
to HCC are usually absent in early stage, liver 
ultrasonography and serum AFP are used for 
the surveillance of HCC in high risk group. 
Positivity for viral markers, larger tumour 
diameter, multiple tumour nodules, the 
presence of vascular invasion, and the 
elevated tumour markers were associated 
with the development of extrahepatic 
metastasis. Most of HCC occurs on the 
background of chronic liver disease including 
chronic hepatitis B and hepatitis C viral 
infection and alcoholic liver disease ultimately 
followed by cirrhosis. However, NAFLD, the 
hepatic manifestation of obesity and related 
metabolic disorders, is now a known-risk factor 
of cryptogenic cirrhosis and HCC.3 
We presented our experience of a rare case of 
HCC in a noncirrhotic liver, presenting as 
chronic back ache with an isolated lumbar 
vertebrae metastasis as the sole manifestation 
in patient with well-known risk factor. This 
case suggests that HCC should be considered 
as one of differential diagnosis in patient 
which presents with spine metastasis, even in 
the absence of liver cirrhosis. 
CONCLUSION 
Extra hepatic metastasis of Hepatocellular 
Carcinoma is not rare. HCC should be included 
in the differential diagnosis of spinal 
metastasis because in some cases it may be the 
initial manifestation of HCC, with or without 
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